Development and first validation of the COPD Assessment Test - PubMed (original) (raw)
Development and first validation of the COPD Assessment Test
P W Jones et al. Eur Respir J. 2009 Sep.
Free article
Abstract
There is need for a validated short, simple instrument to quantify chronic obstructive pulmonary disease (COPD) impact in routine practice to aid health status assessment and communication between patient and physician. Current health-related quality of life questionnaires provide valid assessment of COPD, but are complex, which limits routine use. The aim of the present study was to develop a short validated patient-completed questionnaire, the COPD Assessment Test (CAT), assessing the impact of COPD on health status. 21 candidate items identified through qualitative research with COPD patients were used in three prospective international studies (Europe and the USA, n = 1,503). Psychometric and Rasch analyses identified eight items fitting a unidimensional model to form the CAT. Items were tested for differential functioning between countries. Internal consistency was excellent: Cronbach's alpha = 0.88. Test re-test in stable patients (n = 53) was very good (intra-class correlation coefficient 0.8). In the sample from the USA, the correlation with the COPD-specific version of the St George's Respiratory Questionnaire was r = 0.80. The difference between stable (n = 229) and exacerbation patients (n = 67) was five units of the 40-point scale (12%; p<0.0001). The CAT is a short, simple questionnaire for assessing and monitoring COPD. It has good measurement properties, is sensitive to differences in state and should provide a valid, reliable and standardised measure of COPD health status with worldwide relevance.
Similar articles
- Is the CAT questionnaire sensitive to changes in health status in patients with severe COPD exacerbations?
Agustí A, Soler JJ, Molina J, Muñoz MJ, García-Losa M, Roset M, Jones PW, Badia X. Agustí A, et al. COPD. 2012 Aug;9(5):492-8. doi: 10.3109/15412555.2012.692409. Epub 2012 Sep 7. COPD. 2012. PMID: 22958111 - Dialectal influence on chronic pulmonary disease assessment test: the reliability and validity study.
Pothirat C, Chaiwong W, Phetsuk N, Liwsrisakun C, Bumroongkit C, Deesomchok A, Theerakittikul T, Limsukon A. Pothirat C, et al. Int J Chron Obstruct Pulmon Dis. 2015 Mar 11;10:541-8. doi: 10.2147/COPD.S79041. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25792822 Free PMC article. - Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease.
Nagata K, Tomii K, Otsuka K, Tachikawa R, Otsuka K, Takeshita J, Tanaka K, Matsumoto T, Monden K. Nagata K, et al. Respirology. 2012 Apr;17(3):506-12. doi: 10.1111/j.1440-1843.2012.02131.x. Respirology. 2012. PMID: 22257381 - The use of health status questionnaires in the management of chronic obstructive pulmonary disease patients in clinical practice.
van der Molen T, Diamant Z, Kocks JW, Tsiligianni IG. van der Molen T, et al. Expert Rev Respir Med. 2014 Aug;8(4):479-91. doi: 10.1586/17476348.2014.918851. Epub 2014 Jun 4. Expert Rev Respir Med. 2014. PMID: 24894492 Review. - A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges.
Cazzola M, Hanania NA, MacNee W, Rüdell K, Hackford C, Tamimi N. Cazzola M, et al. Int J Chron Obstruct Pulmon Dis. 2015 Apr 7;10:725-38. doi: 10.2147/COPD.S77368. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25897216 Free PMC article. Review.
Cited by
- The impact of COPD on health status: findings from the BOLD study.
Janson C, Marks G, Buist S, Gnatiuc L, Gislason T, McBurnie MA, Nielsen R, Studnicka M, Toelle B, Benediktsdottir B, Burney P. Janson C, et al. Eur Respir J. 2013 Dec;42(6):1472-83. doi: 10.1183/09031936.00153712. Epub 2013 May 30. Eur Respir J. 2013. PMID: 23722617 Free PMC article. - Extrafine single inhaler triple therapy effectiveness in COPD patients previously treated with multiple-inhaler triple therapy: the TRIWIN study.
Steiropoulos P, Georgatou N, Krommidas G, Bartziokas K, Korkontzelou A, Katerelos P, Efstathopoulos P, Papapetrou D, Theodorakis S, Porpodis K. Steiropoulos P, et al. Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241263439. doi: 10.1177/17534666241263439. Ther Adv Respir Dis. 2024. PMID: 39049587 Free PMC article. - Reliability and validity of an arabic version of the dyspnea-12 questionnaire for Saudi nationals with chronic obstructive pulmonary disease.
Alyami MM, Jenkins SC, Lababidi H, Hill K. Alyami MM, et al. Ann Thorac Med. 2015 Apr-Jun;10(2):112-7. doi: 10.4103/1817-1737.150730. Ann Thorac Med. 2015. PMID: 25829962 Free PMC article. - Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project.
Martín T, Guimarães C, Esquinas C, Torres-Duran M, Turner AM, Tanash H, Rodríguez-García C, Corsico A, López-Campos JL, Bartošovská E, Stæhr Jensen JU, Hernández-Pérez JM, Sucena M, Miravitlles M. Martín T, et al. Respir Res. 2024 Jun 26;25(1):260. doi: 10.1186/s12931-024-02879-y. Respir Res. 2024. PMID: 38926693 Free PMC article. - Novel versus Traditional Inspiratory Muscle Training Regimens as Home-Based, Stand-Alone Therapies in COPD: Protocol for a Randomized Controlled Trial.
Formiga MF, Dosbaba F, Hartman M, Batalik L, Plutinsky M, Brat K, Ludka O, Cahalin LP. Formiga MF, et al. Int J Chron Obstruct Pulmon Dis. 2020 Sep 11;15:2147-2155. doi: 10.2147/COPD.S266234. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32982207 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous